Arg-Gly-Asp-Cys

*This product has been discontinued!*

Films formed from 1,12-diphosphonododecane were treated with zirconium tetra (tert-butoxide) to give surface Zr complex species; derivatives of these surface complexes are stable to hydrolysis under physiological conditions and are mechanically strong. The cell attractive peptide derivative ARG-GLY-ASP-CYS, RGDC can be bound to these surface Zr alkoxide complexes through (maleimido) alkylcarboxylate intermediates. Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation.

Cat. No.	RP10860
Size	Buy in bulk

Ask us a question

Overview Properties

Overview

Synonyms	RGDC
Description	Films formed from 1,12-diphosphonododecane were treated with zirconium tetra (tert-butoxide) to give surface Zr complex species; derivatives of these surface complexes are stable to hydrolysis under physiological conditions and are mechanically strong. The cell attractive peptide derivative ARG-GLY-ASP-CYS, RGDC can be bound to these surface Zr alkoxide complexes through (maleimido) alkylcarboxylate intermediates. Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation.
Sequence	{ARG}{GLY}{ASP}{CYS}
Sequence Shortening	RGDC
Molecular Formula	C₁₅H₂₇N₇O₇S₁
Molecular Weight	449.48

Back

Properties

Purity	> 95%
Solubility	Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
Form	Lyophilized
Storage	Before using, store the peptide in the DRY form at 0-5°C. For best and repeatable results, rehydrate the peptide immediately before using. Do not re-freeze any unused portions.
Note	Inhibits platelet aggregation and fibrinogen binding

Back